SEMMs: Somatically Engineered Mouse Models – A New Tool for Translational Preclinical Research

Time: 10:30 am
day: Day One


  • Animal models of cancer are key to understand the mechanism of action of drugs and their influence on the tumour microenvironment
  • SEMMs with the CRISPR/Cas9 system have optimised and made more agile mouse modelling
  • SEMMs can be integrated in the drug discovery pipeline at different levels